Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors

Conditions: Recurrent Ovarian Carcinoma Interventions: Drug: Dalpiciclib plus letrozole Sponsors: Fengzhi Feng Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials